Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $31.4700 (-3.94%) ($31.3800 - $33.1400) on Wed. Sep. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.24% (three month average) | RSI | 37 | Latest Price | $31.4700(-3.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 1.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(61%) IWO(58%) ARKG(55%) IWC(54%) IBUY(53%) | Factors Impacting EDIT price | EDIT will decline at least -2.12% in a week (0% probabilities). VIXM(-28%) UUP(-14%) VXX(-12%) TBT(-7%) EDOC(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.12% (StdDev 4.24%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $32.6 | 5 Day Moving Average | $32.61(-3.5%) | 10 Day Moving Average | $32.04(-1.78%) | 20 Day Moving Average | $32.6(-3.47%) | To recent high | -15.2% | To recent low | 8.8% | Market Cap | $1.954b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |